Alpha interferon in the treatment of hematologic malignancies
Authors:
- Mark S. RothMRMark S. Roth
- Kenneth A. FoonKFKenneth A. Foon
- 1 November 1986
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 81 (5) , 871-882
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Acute Interstitial Nephritis with the Nephrotic Syndrome Following Recombinant Leukocyte A Interferon Therapy for Mycosis FungoidesNew England Journal of Medicine, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Interferon inhibits the generation of allospecific suppressor T lymphocytes.Journal of Experimental Medicine, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Molecular events in cells transformed by Rous Sarcoma virus.Journal of Cell Biology, 1980
- Induction and kinetics of natural killer cells in humans following interferon therapyNature, 1979
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979
- Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's LymphomaNew England Journal of Medicine, 1978